| Literature DB >> 33946451 |
Abdul-Raouf Al-Mohammadi1, Rehab A Ibrahim2, Ahmed H Moustafa3, Ahmed A Ismaiel2, Azza Abou Zeid2, Gamal Enan2.
Abstract
Kefir beverage (KB) is a fermented milk initiated by kefir grains rich with starter probiotics. The KB produced in this study seemed to contain many chemical compounds elucidated by gas chromatography-mass spectrometry (GC-MS) and IR spectra. These compounds could be classified into different chemical groups such as alcohols, phenols, esters, fatty esters, unsaturated fatty esters, steroids, polyalkenes, heterocyclic compounds and aromatic aldehydes. Both KB and neutralized kefir beverage (NKB) inhibited some pathogenic bacteria including Escherichia coli ATCC11229 (E. coli), Listeria monocytogenes ATCC 4957 (L. monocytogenes), Bacillus cereus ATCC 14579 (B. cereus), Salmonella typhimurium ATCC 14028 (Sal. typhimurium) as well as some tested fungal strains such as Aspergillus flavus ATCC 16872 (A. flavus) and Aspergillus niger ATCC 20611 (A. niger), but the inhibitory activity of KB was more powerful than that obtained by NKB. It also appeared to contain four lactic acid bacteria species, one acetic acid bacterium and two yeast species. Finally, the KB inhibited distinctively both S. aureus and Sal. typhimurium bacteria in a brain heart infusion broth and in some Egyptian fruit juices, including those made with apples, guava, strawberries and tomatoes.Entities:
Keywords: GC-MS analysis; fruit juices; kefir beverage (KB); pathogenic bacteria
Mesh:
Substances:
Year: 2021 PMID: 33946451 PMCID: PMC8125171 DOI: 10.3390/molecules26092635
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Putative identification of the chemical components from KB when subjected to GC-MS (gas liquid chromatographic–mass spectrometry).
| No. | Classification, Compound Name and Structure | Mol. Formula | Area | Parent Ion | Base Peak |
|---|---|---|---|---|---|
|
| |||||
|
| C17H22O9S | 0.77 | 402.0 | 91.00 and | |
|
| |||||
|
| C23H32O2 | 0.28 | 340.0 | 177.0 | |
|
| |||||
|
| 2-Ethylhexyl phthalate | C24H38O4 | 0.32 | 390.0 | 149.0 |
|
| Phorobol 12,13-dihexanoate | C32H48O8 | 0.77 | 560.0 | 43.00 |
|
| 2,3-Dichloro 2-octyl phenyl fumarate | C18H22Cl2O4 | 5.13 | 372.0 | 99.0 |
|
| Nonyl octyl fumarate | C21H38O4 | 5.13 | 355.0 | 71.00 |
|
| 2-Chloro-6-(4-fluorophenyl)-2-octyl fumarate | C18H22ClFO4 | 5.13 | 356.0 | 99.0 |
|
| 2-[(Methylsulfonyloxy)ethyl 4-(6-methyl 1,4-dioxaspiro [4.5]dec-7-yl)butanoate | C16H22O7S | 0.42 | 364.0 | 99.00 and 111.0 |
|
| C22H19Cl2NO3 | 18.21 | 415.0 | 163.0 | |
|
| Bifenthrin | C23H22ClF3O2 | 18.21 | 424.0 | 181.0 |
|
| Cyhalothrin | C23H19ClF3NO3 | 18.21 | 449.0 | 181.0 |
|
| Dihydroobscurinervinediol diacetate | C29H40N2O7 | 1.63 | 528.0 | 69.00 |
|
| 3,4,5,6-Tetrahydro-6-nonul-2 | C14H25O2 | 0.70 | 226.0 | 99.0 |
|
| 6-Heptylotetrahydro-2 | C12H22O2 | 0.44 | 198.0 | 99.00 |
|
| |||||
|
| Methyl hexadecanoate | C17H34O2 | 0.28 | 270.0 | 74.00 |
|
| Methyl octadec-16-enoate | C19H6O2 | 0.47 | 296.0 | 55.00 |
|
| Methyl octadec-10-enoate | C19H6O2 | 0.47 | 296.0 | 55.00 |
|
| 2- (Tetradecycloxyethyl) palmitate | C32H64O3 | 0.77 | 496.0 | 57.00 |
|
| Trimyristin | C45H86O6 | 0.78 | 722.0 | 57.00 |
|
| (E) -2(stearoyloxy) ethyl octadec-9-enoate | C38H72O4 | 1.63 | 592.0 | 99.00 and |
|
| |||||
|
| Methyl 5,6-dihydro-5,6-dihydroxy-(5R, 6R)-10′-Apo-α′-PSI-carotenoate | C28H40O4 | 1.13 | 440.0 | 109.0 |
|
| Tetrahydrofurfuryl oleate | C23H42O3 | 1.97 | 366.0 | 71.00 |
|
| Methyl (10E)-12,12-dideutero-14-oxo-10-nonadecenoate | C20H34D2O3 | 1.63 | 326.0 | 99.00 |
|
| |||||
|
| 17,17-Ethylenedioxy-5,19-cycloaandrast-6-en-3-one | C21H28O3 | 0.35 | 328.0 | 99.00 |
|
| (22E)-Ergosta-7,9(11),22-trien-3-yl acetate | C30H46O2 | 0.35 | 438.0 | 43.00 |
|
| 28-Acetylspirosolan-3-yl acetate | C31H49NO4 | 0.31 | 499.0 | 163.0 and 43.00 |
|
| 3-Oxo-9 | C30H46O3 | 0.42 | 454.0 | 439.0 |
|
| Cholest-5-en-ol | C27H46O | 4.59 | 386.0 | 43.00 and 81.00 |
|
| 3-Methoxy-6-oxo-2′-methylenechloestano [7,8α] cyclobutane | C31H50O2 | 0.99 | 454.0 | 95.00 |
|
| 17-Acetoxy-4,4-dimethyl-3-methoxy-3,19-epoxy androst-8-en-7-ol | C24H36O5 | 0.41 | 404.0 | 270.0 |
|
| |||||
|
| 2,6,10,15,19,23-Hexa methyl-2, | C30H5O | 0.16 | 41.0 | 69.00 |
|
| |||||
|
| 1-(2-Nitro-4-trifluoro-methyl-phenyl)-5-propyl-1 | C15H15F3N4O4 | 3.15 | 372.0 | 43.00 |
|
| C17H19F3N2O3
| 9.57 | 356.0 | 155.0 | |
|
| |||||
|
| m-Phenoxy benzaldehyde | C13H10O2 | 0.43 | 198.0 | 141.0 |
Figure 1GC-MS analysis of KB.
Figure 2IR spectrum in KBr (discs) for the extraction of KB.
Antimicrobial activity of kefir beverage (KB) and neutralized kefir (NKB).
| Tested Organism | Inhibition Zone Diameters (mm) | ||
|---|---|---|---|
| KB | NKB | ||
| 17.0 ± 0.5 | 14 ± 0.2 | 00.002 | |
| 15 ± 0.2 | 18 ± 0.0 | 0.000 | |
| 18 ± 0.45 | 17 ± 0.18 | 0.000 | |
| 21 ± 0.44 | 13 ± 0.25 | 0.000 | |
| 14 ± 0.2 | 10 ± 0.1 | 0.000 | |
| 7 ± 0.18 | 3 ± 0.0 | 0.000 | |
| 2 ± 0.1 | 4 ± 0.0 | 0.000 | |
TCC: American Type Culture Collection.
Figure 3Inhibition of both S. aureus (A) and Sal. typhimurium (B) in BHI broth. Symbols ♦, ■, ∆ refer to control untreated samples, samples treated by 2%, 4% KB, respectively.
Figure 4Inhibition of both S. aureus (A) and Sal. typhimurium (B) in apple juice. Symbols ♦, ■, ∆, refer to control untreated samples, samples treated with 2%, 4% KB, respectively.
Figure 5Inhibition of both S. aureus (A) and Sal. typhimurium (B) in guava juice. Symbols ♦, ■, ∆, refer to control untreated samples, samples treated with 2%, 4% KB, respectively.
Figure 6Inhibition of both S. aureus (A) and Sal. typhimurium (B) in strawberry juice. Symbols ♦, ■, ∆, refer to control untreated samples, juice samples treated with 2%, 4% KB.
Figure 7Inhibition of both S. aureus (A) and Sal. typhimurium (B) in tomato juice. Symbols ♦, ■, ∆, refer to control untreated samples, samples treated with 2%, 4% KB, respectively.